Table 4.
Adjusteda Complication Rates and Healthcare Resource Utilization in the Hospital Setting, 2013–2014
| Parameter | Patients receiving liposomal bupivacaine, N (%) (N = 223) | Patients not receiving liposomal bupivacaine, N (%) (N = 178) | Odds ratio | P value |
|---|---|---|---|---|
| Complications | ||||
| Any complication | 34 (15.2) | 45 (25.3) | 0.54 (95% CI, 0.33–0.89) | .0160 |
| DVT or PE | 2 (0.9) | 2 (1.1) | 0.97 (95% CI, 0.12–7.64) | .9797 |
| Dislocation or fracture | 3 (1.3) | 2 (1.1) | 1.16 (95% CI, 0.19–7.27) | .8741 |
| Infection | 5 (2.2) | 2 (1.1) | 2.11 (95% CI, 0.40–11.12) | .3785 |
| Other | 22 (9.9) | 17 (9.6) | 1.10 (95% CI, 0.56–2.16) | .7780 |
| Healthcare resource utilization | ||||
| Emergency department visit without admission | 32 (14.3) | 17 (9.6) | 1.73 (95% CI, 0.92–3.26) | .0897 |
| Hospital admission (± emergency department visit) | 14 (6.3) | 9 (5.1) | 1.26 (95% CI, 0.53–3.00) | .6038 |
| Return to surgery in <8 weeks | 6 (2.7) | 3 (1.7) | 1.60 (95% CI, 0.39–6.54) | .5162 |
a
The analytic model was adjusted for age and sex.
CI indicates confidence interval; DVT, deep-vein thrombosis; PE, pulmonary embolism.